A key mechanism underlying the cyclical growth of the endometrium is its ab
ility to regenerate a vascular capillary network. In normal cycling human e
ndometrium, angiogenesis is influenced by both endocrine and paracrine fact
ors. Hormonal manipulation of the endometrium, such as that occurring durin
g the use of steroidal contraception, appears to result in capillary prolif
eration and fragility. As a consequence of these vascular changes, contrace
ptive users may be predisposed to unpredictable uterine bleeding, which is
responsible for the high frequency of contraceptive discontinuation. In thi
s paper we address mechanisms responsible for vascular endothelial cell pro
liferation in normal and contraceptive steroid-exposed endometria, We propo
se that regulation of endometrial angiogenesis is mediated indirectly, via
steroid and cytokine actions on vascular endothelial growth factor (VEGF),
and we present data indicating that VEGF expression in normal endometrial s
tromal cells is increased by oestrogens and progestins, Three proinflammato
ry cytokines with angiogenic effects in other systems (i.e. interleukin-1 b
eta, tumour necrosis factor-alpha and interferon-gamma) do not appear to up
-regulate VEGF expression in normal endometrial stromal cells. Well-charact
erized in-vitro models in conjunction with immunohistochemistry provide use
ful experimental systems to study endometrial neovascularization under phys
iological conditions and in those potentially perturbed via the use of cont
raceptive steroids.